{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T08:25:47Z","timestamp":1789892747584,"version":"4.0.1"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"The department of Science and Technology, Government of India"},{"name":"DST","award":["120499"],"award-info":[{"award-number":["120499"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.ijbiomac.2017.10.112","type":"journal-article","created":{"date-parts":[[2017,10,18]],"date-time":"2017-10-18T15:45:45Z","timestamp":1508341545000},"page":"245-258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"special_numbering":"C","title":["Anti-psoriatic and toxicity evaluation of methotrexate loaded chitin nanogel in imiquimod induced mice model"],"prefix":"10.1016","volume":"110","author":[{"given":"Rajitha","family":"Panonnummal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sabitha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0005","first-page":"S83","article-title":"Benefit and risk of methotrexate treatment in rheumatoid arthritis","volume":"22","author":"Rau","year":"2004","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0010","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.clindermatol.2007.11.006","article-title":"Systemic therapies for psoriasis: methotrexate, retinoids, and cyclosporine","volume":"26","author":"Warren","year":"2008","journal-title":"Clin. Dermato."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0015","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1124\/pr.57.2.3","article-title":"Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis","volume":"57","author":"Cronstein","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0020","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nature03723","article-title":"Paths to understanding the genetic basis of autoimmune disease","volume":"435","author":"Rioux","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0025","doi-asserted-by":"crossref","first-page":"E125","DOI":"10.1188\/12.CJON.E125-E132","article-title":"Chemotherapy and biotherapeutic agents for autoimmune diseases","volume":"16","author":"Eric Zack","year":"2012","journal-title":"Clin. J. Oncol. Nurs."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2004.02310.x","article-title":"Immunopathogenic mechanisms in psoriasis","volume":"135","author":"Gudjonsson","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0035","first-page":"319","article-title":"Psoriasis \u2013 Pathophysiology, conventional, and alternative approaches to treatment","volume":"12","author":"Traub","year":"2007","journal-title":"Altern. Med. Rev."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0040","first-page":"87","article-title":"Th1\/Th2 cytokines in psoriasis","volume":"36","author":"Jadali","year":"2007","journal-title":"Iran. J. Public Health"},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0045","first-page":"64","article-title":"Psoriasis Highlights on pathogenesis, adjuvant therapy and treatment of resistant and problematic cases (Part I)","volume":"7","author":"El-Darouti","year":"2010","journal-title":"J. Egypt. Women Dermatol. Soc."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0050","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s40257-013-0017-9","article-title":"The effect of folate supplementation on methotrexate efficacy and toxicity in psoriasis patients and folic acid use by dermatologists in the USA","volume":"14","author":"Al-Dabagh","year":"2013","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0055","first-page":"417","article-title":"Histological and histochemical studies on the effects of methotrexate on the liver of adult male albino Rat","volume":"24","author":"Mohamed","year":"2006","journal-title":"Int. J. Morphol."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0060","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/rheumatology\/ken158","article-title":"Psoriatic arthritis, methotrexate and the liver\u2014are rheumatologists putting their patients at risk?","volume":"47","author":"Lindsay","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0065","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1634\/theoncologist.11-6-694","article-title":"Understanding and managing methotrexate nephrotoxicity","volume":"11","author":"Widemann","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0070","first-page":"187","article-title":"Transdermal iontophoretic delivery of methotrexate: physicochemical considerations","volume":"18","author":"Rachna","year":"2005","journal-title":"Trends Biomater. Artif. Organs"},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0075","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0040-6031(01)00679-7","article-title":"Structural effects of lipophillic methotrexate conjugates on model phospholipid biomembrane","volume":"380","author":"Rosario","year":"2001","journal-title":"Thermo. chemica. Acta."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0080","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ijpharm.2012.01.045","article-title":"Physico-chemical characteristics of methotrexate-entrapped oleic acid-containing deformable liposomes for in vitro trans epidermal delivery targeting psoriasis treatment","volume":"427","author":"Srisuk","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0085","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.carbpol.2011.08.044","article-title":"Synthesis, characterization and in vitro cytocompatibility studies of chitin nanogels for biomedical applications","volume":"87","author":"Sanoj Rejinold","year":"2012","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0090","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.progpolymsci.2014.02.008","article-title":"Chitin and chitosan in selected biomedical applications","volume":"39","author":"Anitha","year":"2014","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0095","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.ijbiomac.2015.11.031","article-title":"Dibutyryl chitin nanoparticles as novel drug carrier","volume":"82","author":"Jain","year":"2016","journal-title":"Int. J. Biol. Macromol"},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0100","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3390\/polym7020235","article-title":"Poriferan Chitin as a versatile template for extreme biomimetics","volume":"7","author":"Petrenko","year":"2015","journal-title":"Polymers"},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0105","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1177\/0885328214563148","article-title":"Chitosan silk-based three-dimensional scaffolds containing gentamicin-encapsulated calcium alginate beads for drug administration and blood compatibility","volume":"29","author":"Mehta","year":"2015","journal-title":"J. Biomater. Appl."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0110","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1016\/j.carbpol.2011.10.040","article-title":"Doxorubicin-loaded pH-responsive chitin nanogels for drug delivery to cancer cells","volume":"87","author":"Jayakumar","year":"2012","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0115","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.carbpol.2012.07.060","article-title":"Development and evaluation of 5-fluorouracil loaded chitin nanogels for treatment of skin cancer","volume":"91","author":"Sabitha","year":"2013","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0120","first-page":"239","article-title":"Curcumin loaded chitin nanogels for skin cancer treatment via the transdermal route","volume":"2","author":"Sabitha","year":"2012","journal-title":"Nanoscale"},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0125","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.colsurfb.2012.11.031","article-title":"In vitro evaluation of paclitaxel loaded amorphous chitin nanoparticles for colon cancer drug delivery","volume":"104","author":"Smitha","year":"2013","journal-title":"Colloids Surf. B"},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0130","first-page":"1","article-title":"Fluconazole loaded chitin nanogels as a topical ocular drug delivery agent for corneal fungal infections","volume":"9","author":"Nishil","year":"2013","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0135","first-page":"193","article-title":"Comparative anti-psoriatic efficacy studies of clobetasol loaded chitin nanogel and marketed cream","volume":"96","author":"Rajitha","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0140","doi-asserted-by":"crossref","first-page":"9399","DOI":"10.1021\/acsami.5b02685","article-title":"Injectable Chitin-Poly(\u03b5-caprolactone)\/Nanohydroxyapatite composite microgels prepared by simple regeneration technique for bone tissue engineering","volume":"7","author":"Arun Kumar","year":"2015","journal-title":"ACS. Appl. Mater. Interfaces"},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0145","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.biomaterials.2011.11.011","article-title":"Skin permeating nanogel for the cutaneous co-delivery of two anti-inflammatory drugs","volume":"33","author":"Shah","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0150","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-0846.2006.00179.x","article-title":"Porcine ear skin: an in vitro model for human skin","volume":"13","author":"Jacobi","year":"2007","journal-title":"Skin Res. Technol."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0155","first-page":"252","article-title":"Development and validation of UV spectrophotometric method for determination of methotrexate incorporated into polymeric implants: application to quality control analyses","volume":"4","author":"Vivian Mara","year":"2012","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0160","first-page":"257","article-title":"In vitro antioxidant activity, lipoxygenase, cyclooxygenase-2 inhibition and DNA protection properties of Memecylon species","volume":"5","author":"Shailasree","year":"2013","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0165","first-page":"168","article-title":"COX and LOX inhibitory potential of Abroma augusta and Desmodium gangeticum","volume":"3","author":"Rekha","year":"2014","journal-title":"JPHYTO"},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0170","first-page":"670","article-title":"Curcumin Inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice","volume":"6","author":"Sun","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0175","first-page":"1","article-title":"Attenuating Janus Kinases (JAK) by tofacitinib effectively prevented psoriasis pathology in various mouse skin inflammation models","volume":"6","author":"Hak","year":"2013","journal-title":"J. Clin. Cell. Immunol"},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0180","first-page":"1","article-title":"Reactive oxygen species prevent imiquimod-induced psoriatic dermatitis through enhancing regulatory T cell function","volume":"3","author":"Kim","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0185","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/jid.2012.318","article-title":"An alternative pathway of imiquimod induced psoriasis like skin inflammation in the absence of interleukin-17 receptor A signalling","volume":"133","author":"El Malki","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0190","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1189\/jlb.1112562","article-title":"Regulatory B cells suppress imiquimod-induced, psoriasis-like skin inflammation","volume":"4","author":"Yanaba","year":"2013","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0195","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature13199","article-title":"Nociceptive sensory neurons drive interleukin-23- mediated psoriasis form skin inflammation","volume":"7503","author":"Riol-Blanco","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0200","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/art.38298","article-title":"Epicutneous application of toll like receptor 7 agonists leads to systemic autoimmunity in wild type mice-A new model of systemic lupus erythematosus","volume":"3","author":"Yokogawa","year":"2014","journal-title":"Arthritis. Rhematol"},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0205","first-page":"7480","article-title":"IL-12, Independently of IFN-\u03b4 plays a crucial role in the pathogenesis of a murine psoriasis like skin disorder","volume":"162","author":"Hong","year":"1999","journal-title":"Immunology"},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0210","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jdermsci.2009.12.006","article-title":"Histological and transcriptional study of angiogenesis and lymphangiogenesis in uninvolved skin, acute pinpoint lesions and established psoriasis plaques: an approach of vascular development chronology in psoriasis","volume":"57","author":"Henno","year":"2010","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0215","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1365-4362.1994.tb01073.x","article-title":"Histologic grading system for psoriasis vulgaris","volume":"33","author":"Trozak","year":"1994","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0220","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/02652048.2012.717115","article-title":"Improved therapeutic performance of dithranol against psoriasis employing systematically optimized nanoemulsomes","volume":"30","author":"Raza","year":"2013","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0225","first-page":"245","article-title":"Characterization of solvatomorphs of methotrexate using thermo analytical and other techniques","volume":"59","author":"Renu","year":"2009","journal-title":"Acta Pharm."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0230","first-page":"2140","article-title":"Transdermal drug delivery systems: an overview","volume":"3","author":"Latheeshjlal","year":"2011","journal-title":"Int. J. PharmTech Res."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0235","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4161\/derm.1.4.9501","article-title":"Nanoparticles and their interactions with the dermal barrier","volume":"1","author":"Schneider","year":"2009","journal-title":"Dermatoendocrinology"},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0240","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4155\/tde.10.16","article-title":"Challenges and opportunities in dermal\/transdermal delivery","volume":"1","author":"Kalpana","year":"2010","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0245","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.4314\/tjpr.v7i3.14694","article-title":"Thiolated chitosans: novel polymers for mucoadhesive drug delivery \u2212A review","volume":"7","author":"Sreenivas","year":"2008","journal-title":"Trop. J. Pharm. Res."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0250","first-page":"798","article-title":"Preparation and in-vitro characterization of oral sustained release chitosan coated cefepime hydrochloride microspheres","volume":"2","author":"Behera","year":"2010","journal-title":"Int. J. PharmTech Res."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0255","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3109\/10837450.2015.1026605","article-title":"A novel nanogel formulation of methotrexate for topical treatment of psoriasis: optimization, in vitro and in vivo evaluation","volume":"21","author":"Avasatthi","year":"2016","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0260","first-page":"42","article-title":"In vitro dissolution kinetics of captopril from microspheres manufactured by solvent evaporation","volume":"32","author":"Sandile","year":"2012","journal-title":"Dissolut. Technol."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0265","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1208\/s12249-010-9380-5","article-title":"In vitro release kinetics and bioavailability of gastroretentive cinnarizine hydrochloride tablet","volume":"11","author":"Ramesh","year":"2010","journal-title":"AAPS. Pharm. Sci.Tech."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0270","first-page":"217","article-title":"Kinetic modeling on drug release from controlled drug delivery systems","volume":"67","author":"Dash","year":"2010","journal-title":"Acta Pol. Pharm."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0275","first-page":"338","article-title":"Development and validation of UV spectrophotometric method for the determination of gliclazide in tablet dosage form","volume":"3","author":"Samina","year":"2011","journal-title":"Pharma. Chemica."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0280","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijbiomac.2010.05.009","article-title":"Three-dimensional chitin-based scaffolds from verongida sponges (Demospongiae: porifera). part II: biomimetic potential and applications","volume":"47","author":"Ehrlich","year":"2010","journal-title":"Int. J. Biol. Macromolec."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0285","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.ijbiomac.2017.03.116","article-title":"\u20183D chitinous scaffolds derived from cultivated marine demosponge Aplysina aerophoba for tissue engineering approaches based on human mesenchymal stromal cells","volume":"104","author":"Mutsenko","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0290","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.ijbiomac.2017.03.161","article-title":"Novel chitin scaffolds derived from marine sponge Ianthella basta for tissue engineering approaches based on human mesenchymal stromal cells: biocompatibility and cryopreservation","volume":"104","author":"Mutsenko","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0295","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/09629350123139","article-title":"Establishment of a consistent L929 bioassay system for TNF-a quantitation to evaluate the effect of lipopolysaccharide, phytomitogens and cytodifferentiation agents on cytotoxicity of TNF-a secreted by adherent human mononuclear cells","volume":"10","author":"Shiau","year":"2001","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0300","first-page":"168","article-title":"Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis","volume":"65","author":"Tian","year":"2007","journal-title":"Bull. NYU Hosp. Jt. Dis."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0305","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/ard.60.8.729","article-title":"Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis","volume":"60","author":"Leader","year":"2001","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0310","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/rheumatology\/39.5.533","article-title":"Methotrexate as a preferential cyclooxygenase 2 inhibitor in whole blood of patients with rheumatoid arthritis","volume":"39","author":"Mello","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0315","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/ard.60.8.729","article-title":"Methotrexate in rheumatoid arthritis anti-inflammatory mechanisms","volume":"60","author":"Cutolo","year":"2001","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0320","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/ar419","article-title":"Molecular action of methotrexate in inflammatory diseases","volume":"4","author":"Chan","year":"2002","journal-title":"Arthritis. Res."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0325","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1016\/j.biomaterials.2013.01.005","article-title":"In vitro antitumor activity of methotrexate via pH-sensitive chitosan nanoparticles","volume":"34","author":"Nogueira","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0330","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1634\/theoncologist.11-6-694","article-title":"Understanding and managing methotrexate nephrotoxicity","volume":"11","author":"Brigitte","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0335","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/j.1365-4632.2010.04500.x","article-title":"Neutrophil elastase promotes proliferation of HaCaT cell line and transwell psoriasis organ culture model","volume":"49","author":"Yang","year":"2010","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0192-0561(98)00068-X","article-title":"Imiquimod applied topically- A novel immune response modifier and new class of drug","volume":"21","author":"Miller","year":"1999","journal-title":"Int. J. Immuno. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12906-016-1325-4","article-title":"Epigallocatechin-3-gallate (EGCG) inhibits imiquimod-induced psoriasis-like inflammation of BALB\/c mice","volume":"16","author":"Zhang","year":"2016","journal-title":"BMC. Complement. Altern. Med."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0350","first-page":"255","article-title":"Formula PSORI-CM01 eliminates psoriasis by inhibiting the expression of keratinocyte cyclin B2, BMC Complement","volume":"16","author":"Jian-an","year":"2016","journal-title":"Altern. Med."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0355","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jaad.2003.09.014","article-title":"50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis","author":"Carlin","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0360","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/exd.12448","article-title":"Skin-penetrating methotrexate alleviates imiquimod-induced psoriasiform dermatitis via decreasing IL-17-producing gamma delta T cells","volume":"23","author":"Byamba","year":"2014","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0365","first-page":"1","article-title":"Methotrexate in psoriasis: from A to Z","volume":"4","author":"Abdulla","year":"2010","journal-title":"J. Turk. Acad. Dermatol"},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0370","doi-asserted-by":"crossref","first-page":"392","DOI":"10.5114\/pdia.2014.47121","article-title":"The possibilities and principles of methotrexate treatment of psoriasis \u2212the updated knowledge","volume":"31","author":"Czarnecka Operacz","year":"2014","journal-title":"Postepy. Dermatol. Alergol"},{"key":"10.1016\/j.ijbiomac.2017.10.112_bib0375","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4103\/0976-500X.81895","article-title":"Toxicological screening","volume":"2","author":"Parasuram","year":"2011","journal-title":"J. Pharmacol. Pharmacother."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813017329690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813017329690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T07:01:43Z","timestamp":1758870103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813017329690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":75,"alternative-id":["S0141813017329690"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2017.10.112","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-psoriatic and toxicity evaluation of methotrexate loaded chitin nanogel in imiquimod induced mice model","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2017.10.112","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}